Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I-II Clinical Study of Taurine for External Use in the Prevention and Treatment of Acute Radiation Skin Injury

NCT06847555 is registered in ClinicalTrials.gov with Shandong Cancer Hospital and Institute as lead sponsor.

NCT NCT06847555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06847555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I-II Clinical Study of Taurine for External Use in the Prevention and Treatment of Acute Radiation Skin Injury
Lead sponsor
Shandong Cancer Hospital and Institute
Phase
Phase 1/2
Overall status
Recruiting
Start date
May 25, 2025
Completion date
September 25, 2027
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

to evaluate the safety of taurine in preventing acute radiation skin injury induced by adjuvant radiotherapy in breast cancer patients